Craig Thalhauser

Craig Thalhauser is a seasoned professional in the pharmaceutical and biotechnology sectors, currently serving as Sr. Director at Genmab since April 2020. Previously, Craig held various roles at Bristol-Myers Squibb from September 2014 to April 2020, including Research Fellow and Assoc. Director of Quantitative Clinical Pharmacology. Craig's earlier experience includes working as a Mathematical Modeler at Immunetrics, Inc. and as a Postdoctoral Scholar at the University of California, Irvine, focusing on mathematical models of signal transduction pathways. Craig began an academic career as a Research Assistant Professor at Arizona State University after earning a Ph.D. in Mathematics with a focus on Computational Bioscience from the same institution, following a Master’s degree in Cellular and Molecular Physiology from Tufts University.